Low-dose decitabine priming endows CAR T cells with enhanced and persistent antitumour potential via epigenetic reprogramming

Insufficient eradication capacity and dysfunction are common occurrences in T cells that characterize cancer immunotherapy failure. De novo DNA methylation promotes T cell exhaustion, whereas methylation inhibition enhances T cell rejuvenation in vivo. Decitabine, a DNA methyltransferase inhibitor a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yao, Tong, Chuan, Dai, Hanren, Wu, Zhiqiang, Han, Xiao, Guo, Yelei, Chen, Deyun, Wei, Jianshu, Ti, Dongdong, Liu, Zongzhi, Mei, Qian, Li, Xiang, Dong, Liang, Nie, Jing, Zhang, Yajing, Han, Weidong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814040/
https://www.ncbi.nlm.nih.gov/pubmed/33462245
http://dx.doi.org/10.1038/s41467-020-20696-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814040/
https://www.ncbi.nlm.nih.gov/pubmed/33462245
http://dx.doi.org/10.1038/s41467-020-20696-x

Ejemplares similares